• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 99 of 100
Images Of Over-The-Counter Medicines And Dietary Supplements By Japanese Drugmakers
FeaturesJapan’s Otsuka to buy U.S. drug maker Avanir for $3.5 billion
By Laura LorenzettiDecember 2, 2014
Las Vegas Hit By Economic Downturn
FinanceWynn Resorts under investigation for potential money laundering
By Tom Huddleston Jr.November 21, 2014
Valeant Offers to Buy Allergan With Pershing's Support
After losing out over Allergan, Valeant announces $2 billion buyback
By Geoffrey SmithNovember 21, 2014
Your pharmacist called. You owe $1.3 trillion.
FeaturesYour pharmacist called. You owe $1.3 trillion.
By Erika FryNovember 20, 2014
American Pharmaceutical Company Pfizer Propose To Takeover British AstraZeneca
Pfizer to pay up to $2 billion for cancer alliance with Germany’s Merck
By Geoffrey SmithNovember 17, 2014
Laid-Off Workers Get Employment Tips And Free Botox Treatments
FinanceAllergan in talks with another bidder as it looks to thwart Valeant
By Laura LorenzettiNovember 6, 2014
CVS Caremark Reports Quarterly Profit Increase Of 25 Percent
RetailCVS Health’s tobacco ban hits retail sales after one month
By Laura LorenzettiNovember 4, 2014
Chris Viehbacher, Chief Executive Officer Of Sanofi Interview
LeadershipSanofi’s CEO ouster: A snowball of bad judgment calls
By Eleanor BloxhamOctober 30, 2014
Chris Viehbacher, Chief Executive Officer Of Sanofi Interview
LeadershipSanofi fires CEO after profit warning on key drug
By Geoffrey SmithOctober 29, 2014
Google X goes teeny-tiny to diagnose disease at its earliest stages
FeaturesGoogle X goes teeny-tiny to diagnose disease at its earliest stages
By Laura LorenzettiOctober 28, 2014
Pfizer’s sales beats expectations even as top drugs lose patent protections
FinancePfizer’s sales beats expectations even as top drugs lose patent protections
By Laura LorenzettiOctober 28, 2014
NIGERIA-HEALTH-DISEASE-EPIDEMIC-EBOLA-LIBERIA
Technical hurdles, not funding, could hinder race for Ebola vaccines
By ReutersOctober 27, 2014
Laid-Off Workers Get Employment Tips And Free Botox Treatments
FinanceAllergan firms up its profit as it continues to rebuff Valeant’s advances
By Laura LorenzettiOctober 27, 2014
Technology
FinanceMerck’s cost cutting pays off as results beat expectations
By Laura LorenzettiOctober 27, 2014
BRITAIN-PHARMACEUTICAL-GSK
FinanceGlaxoSmithKline moving forward with Ebola vaccine
By Laura LorenzettiOctober 22, 2014
1...
  • 96
  • 97
  • 98
  • 99
  • 100
100
Most Popular
Economy
The U.S. government is spending $88 billion a month in interest on national debt—equal to spending on defense and education combinedplaceholder alt text
By Fortune EditorsApril 9, 2026
AI
A Meta employee created a dashboard so coworkers can compete to be the company's No. 1 AI token user—and Zuckerberg doesn't even rank in the top 250placeholder alt text
By Fortune EditorsApril 9, 2026
Success
Gen Z doesn't want your full-time job. They want several part-time roles, and it's reshaping the entire workforceplaceholder alt text
By Fortune EditorsApril 9, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.